Cocrystal Capital Stock from 2010 to 2025

COCP Stock

USD 1.56 0.01 0.65%

Cocrystal Pharma Capital Stock yearly trend continues to be relatively stable with very little volatility. Capital Stock is likely to drop to 8,550. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

9 K

Current Value

8.6 K

Quarterly Volatility

23.2 K

Credit Downgrade

Yuan Drop

Covid

Check Cocrystal Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cocrystal Pharma's main balance sheet or income statement drivers, such as Interest Expense of 1.7 K, Selling General Administrative of 4.1 M or Selling And Marketing Expenses of 8.9 M, as well as many indicators such as Price To Sales Ratio of 383, Dividend Yield of 0.0 or PTB Ratio of 0.69. Cocrystal financial statements analysis is a perfect complement when working with Cocrystal Pharma Valuation or Volatility modules.

Check out the analysis of Cocrystal Pharma Correlation against competitors.

To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.

Latest Cocrystal Pharma's Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Cocrystal Pharma over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Cocrystal Pharma's Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cocrystal Pharma's overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

Cocrystal Capital Stock Regression Statistics

	Arithmetic Mean	31,909
	Geometric Mean	25,418
	Coefficient Of Variation	72.68
	Mean Deviation	13,659
	Median	30,000
	Standard Deviation	23,192
	Sample Variance	537.9M
	Range	90K
	R-Value	(0.09)
	Mean Square Error	571.1M
	R-Squared	0.01
	Significance	0.73
	Slope	(461.40)
	Total Sum of Squares	8.1B

Cocrystal Capital Stock History

	2025	8550.0
	2024	9000.0
	2023	10 K
	2022	8000.0
	2021	98 K
	2020	71 K
	2019	36 K

Other Fundumenentals of Cocrystal Pharma

Issuance Of Capital Stock

Cocrystal Pharma Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Common Stock	Net Receivables	Good Will	Short Term Debt	Intangible Assets	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Long Term Debt	Short Term Investments	Long Term Debt Total	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Property Plant Equipment	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.59	0.02	0.19	0.22	0.77	-0.1	0.57	-0.16	0.66	0.34	0.62	-0.47	0.9	0.03	0.06	-0.15	0.07	0.05	0.03	-0.03	-0.21	0.33	-0.18	0.07
Total Stockholder Equity	0.59		-0.2	-0.19	0.47	-0.06	0.1	0.68	0.09	0.51	-0.28	0.16	-0.51	0.51	0.55	-0.4	-0.67	-0.4	-0.43	-0.13	-0.52	0.01	0.12	0.05	0.19
Net Debt	0.02	-0.2		0.75	0.02	0.2	-0.97	0.14	0.28	0.34	0.46	0.01	0.41	-0.32	-0.66	0.58	0.56	0.59	0.58	0.31	0.59	-0.7	0.55	-0.97	-0.44
Retained Earnings	0.19	-0.19	0.75		-0.14	0.4	-0.77	0.25	-0.24	0.35	0.77	0.15	0.56	-0.08	-0.9	0.91	0.84	0.91	0.89	0.56	0.9	-0.71	0.89	-0.77	0.01
Accounts Payable	0.22	0.47	0.02	-0.14		-0.1	0.02	0.34	0.0	-0.09	-0.25	-0.03	-0.07	0.26	0.33	-0.1	-0.37	-0.1	-0.12	-0.21	-0.23	0.2	-0.21	-0.04	-0.17
Total Liab	0.77	-0.06	0.2	0.4	-0.1		-0.23	0.18	-0.28	0.44	0.65	0.62	-0.18	0.71	-0.39	0.41	0.36	0.41	0.4	0.21	0.4	-0.28	0.34	-0.28	-0.04
Total Current Assets	-0.1	0.1	-0.97	-0.77	0.02	-0.23		-0.21	-0.22	-0.45	-0.47	-0.03	-0.35	0.26	0.63	-0.56	-0.53	-0.57	-0.54	-0.46	-0.57	0.68	-0.6	0.99	0.32
Common Stock	0.57	0.68	0.14	0.25	0.34	0.18	-0.21		0.02	0.54	0.19	0.3	-0.23	0.42	0.05	0.09	-0.18	0.09	0.05	0.13	-0.01	-0.22	0.42	-0.29	0.06
Net Receivables	-0.16	0.09	0.28	-0.24	0.0	-0.28	-0.22	0.02		-0.05	-0.46	-0.41	-0.04	-0.25	0.29	-0.44	-0.31	-0.43	-0.43	-0.24	-0.37	-0.24	-0.17	-0.2	-0.5
Good Will	0.66	0.51	0.34	0.35	-0.09	0.44	-0.45	0.54	-0.05		0.45	0.63	-0.52	0.37	-0.09	0.09	-0.03	0.1	0.06	0.3	0.05	-0.42	0.52	-0.5	0.13
Short Term Debt	0.34	-0.28	0.46	0.77	-0.25	0.65	-0.47	0.19	-0.46	0.45		0.66	0.12	0.22	-0.79	0.83	0.77	0.83	0.82	0.45	0.82	-0.52	0.66	-0.52	-0.04
Intangible Assets	0.62	0.16	0.01	0.15	-0.03	0.62	-0.03	0.3	-0.41	0.63	0.66		-0.61	0.59	-0.12	0.22	0.07	0.22	0.22	-0.01	0.15	-0.1	0.16	-0.14	-0.06
Current Deferred Revenue	-0.47	-0.51	0.41	0.56	-0.07	-0.18	-0.35	-0.23	-0.04	-0.52	0.12	-0.61		-0.52	-0.65	0.62	0.68	0.62	0.63	0.27	0.66	-0.35	0.38	-0.29	-0.07
Net Tangible Assets	0.9	0.51	-0.32	-0.08	0.26	0.71	0.26	0.42	-0.25	0.37	0.22	0.59	-0.52		0.22	-0.06	-0.26	-0.06	-0.07	-0.09	-0.15	0.04	0.06	0.18	0.09
Capital Surpluse	0.03	0.55	-0.66	-0.9	0.33	-0.39	0.63	0.05	0.29	-0.09	-0.79	-0.12	-0.65	0.22		-0.93	-0.97	-0.93	-0.95	-0.45	-0.96	0.62	-0.72	0.63	0.09
Long Term Debt	0.06	-0.4	0.58	0.91	-0.1	0.41	-0.56	0.09	-0.44	0.09	0.83	0.22	0.62	-0.06	-0.93		0.92	1.0	0.99	0.5	0.98	-0.56	0.71	-0.57	-0.06
Short Term Investments	-0.15	-0.67	0.56	0.84	-0.37	0.36	-0.53	-0.18	-0.31	-0.03	0.77	0.07	0.68	-0.26	-0.97	0.92		0.92	0.92	0.49	0.98	-0.54	0.62	-0.5	-0.06
Long Term Debt Total	0.07	-0.4	0.59	0.91	-0.1	0.41	-0.57	0.09	-0.43	0.1	0.83	0.22	0.62	-0.06	-0.93	1.0	0.92		0.99	0.5	0.98	-0.57	0.71	-0.58	-0.07
Deferred Long Term Liab	0.05	-0.43	0.58	0.89	-0.12	0.4	-0.54	0.05	-0.43	0.06	0.82	0.22	0.63	-0.07	-0.95	0.99	0.92	0.99		0.4	0.98	-0.56	0.69	-0.56	-0.1
Long Term Investments	0.03	-0.13	0.31	0.56	-0.21	0.21	-0.46	0.13	-0.24	0.3	0.45	-0.01	0.27	-0.09	-0.45	0.5	0.49	0.5	0.4		0.52	-0.3	0.53	-0.38	0.32
Short Long Term Debt	-0.03	-0.52	0.59	0.9	-0.23	0.4	-0.57	-0.01	-0.37	0.05	0.82	0.15	0.66	-0.15	-0.96	0.98	0.98	0.98	0.98	0.52		-0.57	0.7	-0.56	-0.06
Property Plant Equipment	-0.21	0.01	-0.7	-0.71	0.2	-0.28	0.68	-0.22	-0.24	-0.42	-0.52	-0.1	-0.35	0.04	0.62	-0.56	-0.54	-0.57	-0.56	-0.3	-0.57		-0.75	0.69	0.41
Net Invested Capital	0.33	0.12	0.55	0.89	-0.21	0.34	-0.6	0.42	-0.17	0.52	0.66	0.16	0.38	0.06	-0.72	0.71	0.62	0.71	0.69	0.53	0.7	-0.75		-0.6	0.2
Net Working Capital	-0.18	0.05	-0.97	-0.77	-0.04	-0.28	0.99	-0.29	-0.2	-0.5	-0.52	-0.14	-0.29	0.18	0.63	-0.57	-0.5	-0.58	-0.56	-0.38	-0.56	0.69	-0.6		0.37
Capital Stock	0.07	0.19	-0.44	0.01	-0.17	-0.04	0.32	0.06	-0.5	0.13	-0.04	-0.06	-0.07	0.09	0.09	-0.06	-0.06	-0.07	-0.1	0.32	-0.06	0.41	0.2	0.37

Click cells to compare fundamentals

About Cocrystal Pharma Financial Statements

Cocrystal Pharma shareholders use historical fundamental indicators, such as Capital Stock, to determine how well the company is positioned to perform in the future. Although Cocrystal Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in Cocrystal Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Cocrystal Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Capital Stock	9 K	8.6 K
Issuance Of Capital Stock	3.6 M	3.4 M

Additional Tools for Cocrystal Stock Analysis

When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cocrystal Capital Stock from 2010 to 2025

Latest Cocrystal Pharma's Capital Stock Growth Pattern

Cocrystal Capital Stock Regression Statistics

Cocrystal Capital Stock History

Other Fundumenentals of Cocrystal Pharma

Cocrystal Pharma Capital Stock component correlations

About Cocrystal Pharma Financial Statements

Additional Tools for Cocrystal Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY